Yiming Wang

机构：Qingdao University, Weifang Medical University, Central South University, Yuhuangding Hospital, Kailuan General Hospital, Affiliated Hospital of Qingdao University, Second Xiangya Hospital of Central South University, Xiangya Hospital Central South University · ORCID：0000-0002-6332-1747

发表论文 35 篇 · 总被引 535 次 · h-index 14

代表论文

• Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy (2009 · Journal of Chromatography B · 被引 70)
• Activation of NRF2 Signaling Pathway Delays the Progression of Hyperuricemic Nephropathy by Reducing Oxidative Stress (2023 · Antioxidants · 被引 34)
• Rho Kinase Inhibitor, Fasudil, Attenuates Contrast‐induced Acute Kidney Injury (2017 · Basic & Clinical Pharmacology & Toxicology · 被引 34)
• IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice (2024 · Journal of Translational Medicine · 被引 29)
• Bystander effect in antibody-drug conjugates: Navigating the fine line in tumor heterogeneity (2025 · Critical Reviews in Oncology/Hematology · 被引 28)
• Minocycline-Loaded Poly(α-Lipoic Acid)–Methylprednisolone Prodrug Nanoparticles for the Combined Anti-Inflammatory Treatment of Spinal Cord Injury (2022 · Dove Medical Press (Taylor and Francis Group) · 被引 27)